Seelos eyes chronic ketamine dosing after bagging rights to sublingual candidatenews2021-11-30T14:13:32+00:00November 30th, 2021|Fierce Pharma|
Omicron spurs Celltrion to accelerate development of nebulized COVID-19 antibody cocktailnews2021-11-30T14:08:56+00:00November 30th, 2021|Fierce Pharma|
Aspen closes in on Africa license for Johnson & Johnson’s COVID-19 vaccinenews2021-11-30T14:05:38+00:00November 30th, 2021|Fierce Pharma|
Chinese firms win subcutaneous checkpoint inhibitor approval, beating global heavyweights to new opportunity news2021-11-30T14:05:11+00:00November 30th, 2021|Fierce Pharma|
EpiPen rival Kaléo snapped up in $310M deal by investor groupnews2021-11-30T13:47:47+00:00November 30th, 2021|Fierce Pharma|
COVID-19 tracker: FDA advisory group will discuss Merck antiviral; Companies test vaccines against new variantnews2021-11-29T20:31:42+00:00November 29th, 2021|Fierce Pharma|
COVID-19 tracker: Omicron variant was in Europe before it was found in South Africanews2021-11-29T20:31:42+00:00November 29th, 2021|Fierce Pharma|
COVID-19 tracker: First omicron case detected in USnews2021-11-29T20:31:42+00:00November 29th, 2021|Fierce Pharma|
COVID-19 tracker: Biden’s winter plan includes tighter travel rules and free at-home testsnews2021-11-29T20:31:42+00:00November 29th, 2021|Fierce Pharma|
Pfizer boosts Paxlovid manufacturing capacity as Merck’s rival COVID pill hits surprise efficacy setbacknews2021-11-29T16:38:24+00:00November 29th, 2021|Fierce Pharma|
